Moghe slc35a2
Web1 jul. 2024 · MOGHE is a focal MCD causing childhood-onset seizures, often refractory to anti-seizure medication and therefore subjected to epilepsy surgery. It is characterized … Web28 okt. 2024 · SLC35A2 encodes a UDP-galactose transporter, previously implicated in other malformations of cortical development (MCD) and a rare type of congenital …
Moghe slc35a2
Did you know?
Web19 jan. 2024 · SLC35A2 solute carrier family 35 member A2 Gene ID: 7355, updated on 19-Jan-2024 Gene type: protein coding Also known as: UGT; CDGX; UGAT; UGT1; UGT2; … WebBackground and objectives: The SLC35A2 gene, located at chromosome Xp11.23, encodes for a uridine diphosphate (UDP)-galactose transporter. We describe clinical, genetic, …
WebRESULTS: Two main phenotypes were associated with brain somatic SLC35A2 variants: 1) early epileptic encephalopathy (EE, 39 patients) with epileptic spasms as the predominant seizure type and moderate to severe intellectual disability, and 2) drug-resistant focal epilepsy (DR-FE, 8 patients) associated with normal/borderline cognitive function … WebSLC35A2, which is located at Xp11.23, encodes a uridine diphosphate (UDP)-galactose transporter, a member of the nucleotide-sugar transporter family that transports galactose from the cytosol or nucleus into Golgi vesicles [ 9, 12 ].
WebFrequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) Research output: Contribution to journal › Article › Academic › peer-review Web(MOGHE) is often also located in the frontal lobe and is frequently associated with somatic mutations in the SLC35A2 gene affecting the glycosylation pathway. In contrast, genetic mutations have notcommonlybeenseenthus far inFCD Type I lesions, but recent unpublished data, reviewed by Blümcke and colleagues,1 suggest that DNA methylation ...
Web31 mrt. 2024 · Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) is a new entity frequently associated with refractory epilepsy and neurodevelopmental disorders. Recently, it has been associated to SLC35A2 (Solute Carrier Family 35 Member A2) brain mosaic pathogenic variants.
Web31 jan. 2024 · Bonduelle et al. acta neuropathol commun 2024 9:3 https:doi.org10.1186s40478-020-01085-3 RESEARCH Frequent SLC35A2 brain mosaicism in mild malformation of cortical development… j and l home medical equipment georgetown kyWebwith SLC35A2 somatic mutations in the brain who were finally di-agnosed with MOGHE. Materials and Methods 1. Selection of subjects We retrospectively collected a series of patients with intractable pe - diatric epilepsy who underwent epilepsy resection surgery and were confirmed to have SLC35A2 brain somatic mutations from j and l paint and bodyWeb1 jul. 2024 · Europe PMC is an archive of life sciences journal literature. j and l opticalWebIntroduction . There is an emerging interest in the literature about MOGHE (Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia and Epilepsy). We report the case of an epileptic patient with MOGHE. Case Report . A 33-year-old male patient was suffering from refractory focal epilepsy since adolescence. MRI … lowest hour work week countryWeb21 mrt. 2024 · SLC35A2 (Solute Carrier Family 35 Member A2) is a Protein Coding gene. Diseases associated with SLC35A2 include Congenital Disorder Of Glycosylation, Type Iim and Isolated Focal Cortical Dysplasia Type Ia . Among its related pathways are Transport of vitamins, nucleosides, and related molecules and Disorders of transmembrane … j and l optical corporationWebSLC35A2-CDG is a rare type of X-linked CDG with more than 60 reported cases. We retrospectively analyzed clinical phenotypes and SLC35A2 genotypes of four cases of SLC35A2-CDG from four unrelated families of Han ethnicity in China. All patients had infantile onset epilepsies that were completely or partly resistant to multiple anti-epileptic … j and l plasticsWebThese topics include the progress in genotype-phenotype association studies of Focal Cortical Dysplasia (FCD) leading to the discovery of new molecularly defined entities, i.e. mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE), SLC35A2 altered. lowest house cost in us